No Data
Rocket Pharmaceuticals Shares Slide on Pricing $100.3M Stock Offering
Rocket Pharmaceuticals (NASDAQ:RCKT) shares down 3.9% after-hours on pricing an underwritten public offering of 6.8M shares of its common stock at a public offering price of $14.75/share for expected
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $65.00 at Chardan Capital
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) had its target price boosted by Chardan Capital from $62.00 to $65.00 in a research note issued to investors on Friday morning, The Fly reports. Char
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational genetic the
Rocket Is a Late-stage Biotech Co Focused on Genetic Therapies for Rare Childhood Disorders >RCKT
Rocket Is a Late-stage Biotech Co Focused on Genetic Therapies for Rare Childhood Disorders >RCKT
Rocket: Morgan Stanley, J.P. Morgan, SVB Securities Acting as Book-Running Managers >RCKT
Rocket: Morgan Stanley, J.P. Morgan, SVB Securities Acting as Book-Running Managers >RCKT
Rocket: Offering Expected to Close on or About Oct 6 >RCKT
Rocket: Offering Expected to Close on or About Oct 6 >RCKT
Rocket Expects to Raise $100.3M in Gross Proceeds From Offering >RCKT
Rocket Expects to Raise $100.3M in Gross Proceeds From Offering >RCKT
Rocket Has Granted Underwriters Option for Additional 1.02M Shrs >RCKT
Rocket Has Granted Underwriters Option for Additional 1.02M Shrs >RCKT
Rocket Pharmaceuticals Offering of 6.8M Shrs Prices at $14.75 Each >RCKT
Rocket Cos. Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Rocket Cos. Inc. (RKT) rose 4.11% to $6.58 Monday, on what proved to be an all-around favor
Loading...
